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A B S T R A C T
This prospective study compared the clinical and
socio-economic impact of laboratory-confirmed
influenza and respiratory syncytial virus (RSV)
infection on healthy children and their families.
Among 1520 otherwise healthy children aged
< 15 years attending the Emergency Department
for acute conditions other than trauma, influenza
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viruses and RSV were found in 234 (15.4%) and
116 (7.6%; p < 0.0001) patients, respectively. The
fact that influenza has a similar global clinical
impact on the community to that of RSV infection,
but represents a greater socio-economic burden,
may contribute to broadening the acceptance of
influenza vaccination.
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In the northern hemisphere, influenza viruses
and respiratory syncytial virus (RSV) cause
epidemics between November and April, and
are the main aetiological agents of acute respir-
atory diseases in infants and children during this
period [1,2]. Although the infections caused by
these pathogens can have similar clinical pic-
tures, involving all sections of the respiratory
tract, RSV is usually considered to be much more
important than influenza viruses, as it is the
main cause of bronchiolitis, which is one of the
main reasons for hospitalisation of children in
the first years of life, and has a major impact on
public health resources [2,3]. However, recent
data suggest that paediatric influenza can play a
much more important clinical role than previ-
ously thought, with important socio-economic
consequences for the patients’ families [4–12].
The present prospective study was designed to
analyse the clinical and socio-economic impact of
laboratory-confirmed cases of influenza and RSV
infection on healthy children and their families.
Between 1 November 2002 and 31 March 2003,
subjects aged < 15 years were enrolled who
attended the Emergency Department at the
Pediatric Institute of the University of Milan
(Italy) twice-weekly (Wednesday and Sunday)
because of an acute condition other than trauma.
Other exclusion criteria were concomitant chronic
diseases leading to an increased risk of the
complications of influenza or RSV infection [2,7].
The protocol was approved by the Institutional
Review Board of the University of Milan, and the
written informed consent of a parent or legal
guardian was acquired.
Upon enrolment, each patient’s demographic
characteristics and medical history were recorded
using a standardised written questionnaire. After
a complete physical examination, the children
were divided into different disease groups using
well-established criteria [13]. Virocult (Medical
Wire and Equipment, Corsham, UK) nasopharyn-
geal swabs were collected for the detection of
influenza viruses and RSV RNA by RT-PCR as
described previously [14–17].
The medical history of the children studied
was re-evaluated 5–7 days after enrolment, and
until the resolution of their illness, by means of
interviews and clinical examinations by trained
investigators using a standard questionnaire.
During these evaluations, information was also
obtained concerning acute illnesses and related
morbidity among household contacts. The data
were analysed using SAS for Windows v. 12
(SAS Institute, Cary, NC, USA). Parametric data
were compared using analysis of variance
(ANOVA); abnormally distributed or non-para-
metric data were analysed using the Kruskal–
Wallis test. Categorical data were analysed using
contingency analysis and chi-squared or Fisher’s
tests.
The study involved 1520 otherwise healthy
children (815 males; mean age 3.41 ± 3.06 years).
Influenza viruses were demonstrated in 234
patients (15.4%), including 228 with influenza A
virus (97.5%; 148 H3N2, 64.9%; 80 H1N1, 35.1%)
and six (2.5%) with influenza B virus, while RSV
was detected in 116 patients (7.6%; p < 0.0001 vs.
influenza-positive cases). Influenza-positive cases
were observed significantly more frequently
among children aged > 2 years (66.7% vs.
35.3%; p < 0.0001), whereas RSV was detected
significantly more frequently among patients
aged < 2 years (64.7% vs. 33.3%; p < 0.0001).
Table 1 shows the clinical presentations by aetio-
logical diagnosis. At enrolment, most diagnoses
involved the respiratory system. The differences
in clinical presentation between the influenza-
and RSV-positive children were similar regardless
of age.
Upon admission, diagnostic tests were used
more frequently in RSV-positive than in influ-
enza-positive children, although the difference
was statistically significant only in the case of
microbiological tests (9.5% vs. 2.1%; p 0.004). The
frequency of antibiotic prescriptions was similar
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for both groups, whereas anti-pyretics were used
significantly more frequently with influenza-
positive patients (82.5% vs. 50.0%; p < 0.0001),
and bronchodilators and steroids were adminis-
tered significantly more often to RSV-positive
children (29.3% vs. 6.4%, p < 0.0001, and 28.4%
vs. 11.5%, p < 0.0001, respectively). Hospitalisa-
tion was required for a significantly larger
proportion of RSV-positive children (17.2% vs.
5.6%; p 0.0007), whereas school absence was
significantly more prevalent among influenza-
positive patients (median, 12 vs. 5 days; p 0.003).
The between-group differences in diagnostic
procedures and therapeutic approaches remained
similar regardless of the patients’ ages, whereas
the frequency of hospitalisation was significantly
higher only for the RSV-positive patients aged
< 2 years (22.7% vs. 6.4%; p < 0.05).
Table 2 shows that the household contacts of
the influenza-positive children had significantly
more diseases resembling that of the infected
child than those of the RSV-positive children, and
required significantly more medical visits,
received more anti-pyretics, and missed signifi-
cantly more working or school days. These
differences were more evident among mothers
and siblings, and remained similar regardless of
the patients’ ages.
To the best of our knowledge, this is the first
prospective study, starting from laboratory-con-
firmed diagnoses, to compare simultaneously
the clinical and socio-economic impact of influ-
enza and RSV infections in otherwise healthy
children on themselves and their households.
The clinical data confirmed that RSV affects
younger children more frequently, involves
mainly the lower respiratory tract, and (especi-
ally in the first 2 years of life) often leads to
hospitalisation, even in the absence of any
known risk-factor [3–6,18,19]. However, the
importance of influenza viruses cannot be con-
sidered marginal, since the present results
(which extend those of previous studies) [4,20]
indicate that a substantial number of children of
all ages, without any risk-factor, attend the
Emergency Department with influenza during
epidemic periods, that > 5% of influenza-posit-
ive children of any age attending the Emergency
Department may have a severe illness requiring
hospitalisation, and that most children spread
the infection among the members of their
household. In terms of socio-economic impact,
the greater relevance of influenza in healthy
children for household contacts is demonstrated
by the higher incidence of similar disease in the
parents and siblings of influenza-positive cases,
a larger number of whom required medical
visits and anti-pyretics, and missed work or
school days. These findings indicate that influ-
Table 2. Socio-economic impact of influenza and RSV
infection on the household contacts of the study children
Characteristics
Household contacts
of influenza-positive
children (n = 651)
Household contacts
of RSV-positive
children (n = 311)
Disease similar to that of
the infected child (%)
119 ⁄ 651 (18.3)a 25 ⁄ 311 (8.0)
Mothers, n (%) 49 ⁄ 234 (20.9)b 13 ⁄ 116 (11.2)
Fathers, n (%) 24 ⁄ 234 (10.3) 6 ⁄ 116 (5.2)
Siblings, n (%) 46 ⁄ 183 (25.1)b 6 ⁄ 79 (7.6)
Additional medical visits (%) 88 ⁄ 651 (13.5)a 16 ⁄ 311 (5.1)
Mothers, n (%) 27 ⁄ 234 (11.5)b 5 ⁄ 116 (4.3)
Fathers, n (%) 15 ⁄ 234 (6.4) 3 ⁄ 116 (2.6)
Siblings, n (%) 46 ⁄ 183 (25.1)b 8 ⁄ 79 (10.1)
Anti-pyretic prescriptions (%) 107 ⁄ 651 (16.4)a 15 ⁄ 311 (4.8)
Mothers, n (%) 43 ⁄ 234 (18.4)b 7 ⁄ 116 (6.0)
Fathers, n (%) 20 ⁄ 234 (8.6)b 2 ⁄ 116 (1.7)
Siblings, n (%) 44 ⁄ 183 (24.0)b 6 ⁄ 79 (7.6)
Antibiotic prescriptions (%) 35 ⁄ 651 (5.4) 11 ⁄ 311 (3.5)
Mothers, n (%) 9 ⁄ 234 (3.9) 4 ⁄ 116 (3.4)
Fathers, n (%) 7 ⁄ 234 (3.0) 2 ⁄ 116 (1.7)
Siblings, n (%) 19 ⁄ 183 (10.4) 4 ⁄ 79 (5.1)
Hospitalisation (%) 2 ⁄ 651 (0.3) 0 ⁄ 311 (0)
Mothers, n (%) 0 ⁄ 234 (0) 0 ⁄ 116 (0)
Fathers, n (%) 0 ⁄ 234 (0) 0 ⁄ 116 (0)
Siblings, n (%) 2 ⁄ 183 (1.1) 0 ⁄ 79 (0)
Missed working days by
mothers, median (range)
4 (1–9)b 2 (2–5)
Missed working days by
fathers, median (range)
3 (2–8)b 1 (1–4)
Missed school days,
median (range)
6 (2–15)b 3 (2–5)
RSV, respiratory syncytial virus.
ap < 0.0001 and bp < 0.05 vs. RSV-positive cases; no other statistically significant
differences.
Table 1. Clinical presentation of the patients according to
aetiological diagnosis
Clinical presentation
Influenza-positive
cases (n = 234)
RSV-positive
cases (n = 116)
Presence of fevera (%) 212 (90.6)c 77 (66.4)
High-grade feverb (%) 179 (76.5)c 60 (51.7)
Respiratory tract infection (%) 190 (81.2)d 108 (93.1)
Upper respiratory tract infection (%) 144 (61.5)d 47 (40.5)
Common cold (%) 33 (14.1) 12 (10.3)
Pharyngitis (%) 75 (32.1)d 19 (16.4)
Acute otitis media (%) 33 (14.1) 14 (12.1)
Croup (%) 3 (1.3) 2 (1.7)
Lower respiratory tract infection (%) 46 (19.7)c 61 (52.6)
Acute bronchitis (%) 27 (11.5) 15 (12.9)
Wheezing (%) 10 (4.3)* 25 (21.6)
Pneumonia (%) 9 (3.9)* 21 (18.1)
Gastrointestinal tract infection (%) 8 (3.4) 7 (6.0)
Fever without source (%) 27 (11.6)d 1 (0.9)
Febrile seizures (%) 9 (3.8)d 0
RSV, respiratory syncytial virus.
aDefined as an axillary temperature ‡ 37.6C or a rectal temperature ‡ 38C.
bDefined as an axillary temperature ‡ 39C or a rectal temperature ‡ 39.5C.
cp < 0.0001 and dp < 0.05 vs. RSV-positive cases; no other statistically significant
differences.
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enza in healthy children has a considerable
impact on their families, and thereby justifies
extending the recommendation to vaccinate
healthy children [7].
In conclusion, the present study showed that
the global clinical impact of influenza on the
community may be similar to that of RSV infec-
tion, and that it represents a greater socio-econo-
mic burden. These data may help to modify the
mistaken attitude of some physicians and parents
towards influenza and its prevention, and may
contribute to broadening the acceptance of influ-
enza vaccination.
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